Surgery Websites
Transplant Surgery »  Meet the Team »  Pediatric Hepatology »  Philip Rosenthal, M.D.
Philip Rosenthal, M.D.

Philip Rosenthal, M.D.

  • Professor of Pediatrics and Surgery Director of Pediatric Hepatology Research Director, Pediatric Hepatology

Contact Information

Academic Office
 Room MU 415, Box 0136
University of California, San Francisco
San Francisco, CA 94143-0136
(415) 476-5892
(415) 476-1343 Fax
[email protected]
Open Popup

Education

1967-71 State Univ. of N.Y. at Albany, Albany, NY, B.S. Magna Cum Laude, Biology
1971-75 State Univ. of N.Y. Downstate Med. Ctr. Brooklyn, NY, M.D. Magna Cum Laude

Residencies

  • 1975-76 Albert Einstein/Bronx Mun. Hosp., NY, Intern Pediatrics
  • 1976-78 Albert Einstein/Bronx Mun. Hosp., NY, Resident Pediatrics

Fellowships

  • 1978-81 University of California, San Francisco, Fellow Pediatric Gastroenterology

Board Certifications

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Subspeciality in Pediatric Gastroenterology
  • American Board of Pediatrics, Certificate of Added Qualification in Transplant Hepatology

Program Affiliations

  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Center
  • Pediatric Liver Transplant Program
  • Pediatric Intestinal Rehabilitation and Transplantation Program

Clinical Expertise

Research Interests

  • Bioartificial liver devices
  • Genetics and immunology of biliary atresia
  • Idiopathic neonatal hepatitis
  • Pediatric Acute Liver Failure (PALF)
  • Quality of life after liver transplants

Biography

Philip Rosenthal, M.D. is Professor of Pediatrics and Surgery, Medical Director of the Pediatric Liver Transplant Program. and Director of Pediatric Hepatology at UCSF.  Rosenthal completed his medical training at Downstate Medical Center and the Albert Einstein Medical Center in New York. He then completed a fellowship in pediatric gastroenterology at UCSF. He joined the UCSF faculty in 1995 after serving as Professor of Pediatrics at University of California, Los Angeles (UCLA). 

A  pediatric hepatologist at the UCSF Benioff Children's Hospital, Rosenthal is internationally renowned for the care of children with liver disease, including liver cancer, and  those undergoing liver transplantation. In addition, Rosenthal has and currently serves as Principal Investigator on numerous clinical trials to improve the care of patients with pediatric liver disease.

Rosenthal has won numerous honors for his research including work on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia and the quality of life after liver transplants in children. He is a consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). He is also on editorial boards and a regular reviewer for leading professional journals.

Awards & Honors

  Award  
  Confired By    
  Date    
  • Murray Davidson Award
  • American Academy of Pediatrics
  • 2013
  • Chancellor's Award for Public Service
  • UCSF
  • 2002

    • Research Overview

    Rosenthal is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary disease, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children. 

    Clinical Research

    Rosenthal is principal investigator on numerous clinical trials including the following:

    View all trials 

    Research & Funding

    Data provided by UCSF Profiles, powered by CTSI
    • Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda
      Sponsor:
      Sponsor ID:
      Funding Period:
      Apr 2020
      -
      Mar 2025
      Co-Principal Investigator
    • Childhood Liver Disease Research Network (ChiLDReN) - UCSF (CC)
      Sponsor:
      Sponsor ID:
      Funding Period:
      Sep 2002
      -
      May 2024
      Principal Investigator
    • Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jun 2018
      -
      May 2023
      Principal Investigator

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 398
    Data provided by UCSF Profiles, powered by CTSI
    1. Boster JM, Goodrich NP, Spino C, Loomes KM, Alonso EM, Kamath BM, Sokol RJ, Karpen S, Miethke A, Shneider BL, Molleston JP, Kohli R, Horslen SP, Rosenthal P, Valentino PL, Teckman JH, Hangartner TN, Sundaram SS, Childhood Liver Disease Research Network (ChiLDReN). Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. Hepatol Commun. 2023 11 01; 7(11). View in PubMed
    2. Schwarzenberg SJ, King WC, Ling SC, Murray KF, Mogul D, Rosenthal P, Rodriguez-Baez N, Teckman J, Schwarz KB, Hepatitis B Research Network (HBRN). Change in Health-related Quality of Life in Youth with Chronic Hepatitis B Living in North America:A 5-year Cohort Study. J Pediatr Gastroenterol Nutr. 2023 Sep 27. View in PubMed
    3. Conrad MD, Asua V, Garg S, Giesbrecht D, Niaré K, Smith S, Namuganga JF, Katairo T, Legac J, Crudale RM, Tumwebaze PK, Nsobya SL, Cooper RA, Kamya MR, Dorsey G, Bailey JA, Rosenthal PJ. Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. N Engl J Med. 2023 Aug 24; 389(8):722-732. View in PubMed
    4. Roh ME, Zongo I, Haro A, Huang L, Somé AF, Yerbanga RS, Conrad MD, Wallender E, Legac J, Aweeka F, Ouédraogo JB, Rosenthal PJ. Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study. J Infect Dis. 2023 10 03; 228(7):926-935. View in PubMed
    5. Rosenthal PJ. Proteasome inhibitors: The next generation of antimalarial drugs? Cell Chem Biol. 2023 05 18; 30(5):413-415. View in PubMed
    6. View All Publications

    In the News

    • Teen Liver Transplant Recipient to Honor Donor at 2013 Rose Parade

      UCSF Transplant Surgery - December 28, 2012
      The Garcia family and their transplant team
      Alfonso Garcia and his parents pose with the UCSF medical team that cared for him during his 2010 life-saving liver transplant. From left: mother Marta Garcia; Emily Perito, MD; nurse practitioner Susan Diaz, MSN; Garcia; Philip Rosenthal, MD; and father Oscar Garcia. Alfonso Garcia still carries around a baseball cap that belonged to a 22-year-old man who passed away in 2010 having never met him. But the cap is just a small token of an even bigger reminder that the 18-year-old college [...]

    • Father Saves Son by Donating Part of His Liver

      UCSF Transplant Surgery - October 01, 2001
      UCSF Medical Center staff performed the biopsy and told us the next day that William had a condition called biliary atresia, which is the closure or absence of some or all of the major bile ducts. That evening William had surgery to assess the damage to his liver and to open bile ducts. Later, during clinic visits with Dr. Phil Rosenthal (pictured left) and pediatric nurse practitioner and Liver Transplant Coordinator Chris Mudge, we learned about a relatively new procedure call a living [...]

    Patient Stories

     

     
    Site Directory
      X